Stock Research: Prestige

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Prestige

NYSE:PBH US74112D1019
61
  • Value
    84
  • Growth
    5
  • Safety
    Safety
    29
  • Combined
    29
  • Sentiment
    96
  • 360° View
    360° View
    61
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Prestige Consumer Healthcare Inc. is a consumer healthcare products company. It operates in the consumer healthcare industry and its brands include Monistat, Summer’s Eve, BC, Goody's, Clear Eyes, and others. It operates in North America, Australia, and other international markets. In the last fiscal year, the company had a market cap of $3,699 million, profits of $634 million, revenue of $1,138 million, and 600 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 61 (better than 61% compared with alternatives), overall professional sentiment and financial characteristics for the stock Prestige are above average. The 360° View is based on consolidating four consolidated indicators, with half below and half above average for Prestige. The consolidated Sentiment Rank has a good rank of 96, which means that professional investors are more optimistic about the stock than for 96% of alternative investment opportunities. It also rates well regarding its financing structure, with the consolidated Safety Rank at 84 or better than 84% of its peers when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. But the stock is expensive and expects low growth. The consolidated Value Rank is only 29, meaning that the share price of Prestige is on the high side, compared with indicators such as revenues, profits, and invested capital. The company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, invested capital growth,and stock returns, with its Growth Rank at 5. ...read more

more
Index
D.J. US Pharmaceutical
S&P MIDCAP
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
29 28 46 67
Growth
5 43 65 69
Safety
Safety
84 48 50 26
Sentiment
96 100 90 99
360° View
360° View
61 63 89 91
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
97 41 88 39
Opinions Change
50 97 50 50
Pro Holdings
n/a 94 60 96
Market Pulse
85 93 83 94
Sentiment
96 100 90 99
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
29 28 46 67
Growth
5 43 65 69
Safety Safety
84 48 50 26
Combined
29 23 62 57
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
62 45 56 68
Price vs. Earnings (P/E)
41 39 43 55
Price vs. Book (P/B)
45 41 43 64
Dividend Yield
1 1 1 1
Value
29 28 46 67
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
18 18 24 25
Profit Growth
34 39 100 65
Capital Growth
17 57 54 46
Stock Returns
37 69 55 97
Growth
5 43 65 69
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
55 38 32 34
Refinancing
47 28 31 19
Liquidity
79 70 72 60
Safety Safety
84 48 50 26

Similar Stocks

Discover high‑ranked alternatives to Prestige and broaden your portfolio horizons.

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Intuit

NasdaqGS:INTU
Country: USA
Industry: Application Software
Size: X-Large
Full Stock Analysis

Lithia Motors

NYSE:LAD
Country: USA
Industry: Automotive Retail
Size: X-Large
Full Stock Analysis

Micron

NasdaqGS:MU
Country: USA
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.